Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Stanford University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Epilepsy Foundation
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00285740
First received: January 31, 2006
Last updated: December 14, 2007
Last verified: December 2007
  Purpose

This study involves a form of group therapy called Cognitive Behavioral Therapy or CBT for depressed patients with Epilepsy. The CBT groups will be tailored for an epilepsy clinic population. There are 12 sessions of therapy in the study held once a week for 12 weeks.


Condition Intervention
Epilepsy
Depressive Disorder
Behavioral: Cognitive Behavioral Therapy (CBT) in a Group Format

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Beck Depression Inventory

Secondary Outcome Measures:
  • NDDI

Estimated Enrollment: 60
Study Start Date: August 2005
Estimated Study Completion Date: January 2007
Detailed Description:

Depression is frequent in PWE and often missed for unclear reasons. Busy neurology clinics and their overworked physicians often lack psychiatric backup that may make inquiring about psychological issues problematic. In the psychiatric community, awareness of the need for depression intervention in the primary care clinic has been recognized for many years and several treatment models exist. This study will attempt to use one such model, i.e. Cognitive-Behavioral Therapy (CBT) using a group format and tailoring its use for an epilepsy clinic population.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria::- Patients will be screened with the Beck Depression Inventory. Those reaching the positive cut-off score of 11 (indicating at least a mild depression) will be entered into the study. Patients entered on antidepressants will be held at a stable dosage. Anti-epileptic drugs will also be maintained on the same dosage at entry into the study when possible clinically, after consultation with their neurologist. Exclusion Criteria:- Patients will be excluded if there is any active serious medical conditions, Standard Score<70 as assessed via the Wide Range Achievement Test, psychotic or substance abuse issues, those who are unable to maintain a stable dose of medications for the duration of study.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00285740

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Epilepsy Foundation
Investigators
Principal Investigator: John J Barry Stanford University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00285740     History of Changes
Other Study ID Numbers: 2903, 34121
Study First Received: January 31, 2006
Last Updated: December 14, 2007
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Depressive Disorder
Depression
Epilepsy
Mood Disorders
Mental Disorders
Behavioral Symptoms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on July 28, 2014